Alps Advisors Inc Deciphera Pharmaceuticals, Inc. Transaction History

Alps Advisors Inc

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$13.58 - $17.36 $99,025 - $126,589	7,292 Added 14.67%	56,991 $896,000
Q4 2023 Feb 14, 2024	SELL	$10.11 - $16.54 $86,096 - $140,854	-8,516 Reduced 14.63%	49,699 $801,000
Q3 2023 Nov 14, 2023	BUY	$12.46 - $15.48 $6,155 - $7,647	494 Added 0.86%	58,215 $740,000
Q2 2023 Aug 14, 2023	BUY	$13.28 - $15.96 $766,534 - $921,227	57,721 New	57,721 $812,000
Q4 2020 Feb 03, 2021	SELL	$51.77 - $66.18 $3.72 Million - $4.76 Million	-71,891 Closed	0 $0
Q3 2020 Nov 04, 2020	SELL	$43.8 - $58.16 $188,602 - $250,436	-4,306 Reduced 5.65%	71,891 $3.69 Million
Q2 2020 Aug 05, 2020	SELL	$37.05 - $65.03 $824,584 - $1.45 Million	-22,256 Reduced 22.61%	76,197 $4.55 Million
Q1 2020 May 06, 2020	SELL	$33.63 - $69.4 $146,895 - $303,139	-4,368 Reduced 4.25%	98,453 $4.05 Million
Q4 2019 Feb 07, 2020	BUY	$31.7 - $69.93 $158,880 - $350,489	5,012 Added 5.12%	102,821 $6.4 Million
Q3 2019 Nov 04, 2019	BUY	$19.95 - $38.85 $356,785 - $694,793	17,884 Added 22.38%	97,809 $3.32 Million
Q2 2019 Aug 07, 2019	BUY	$21.05 - $26.21 $1.68 Million - $2.09 Million	79,925 New	79,925 $1.8 Million

343K

500

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

Stay updated on Alps Advisors Inc with notifications on news.